Rilonacept-CAPS and Beyond-Reference-Cited by-同舟云学术

Rilonacept-CAPS and Beyond

Published:2009-12 Issue:1 Volume:1182 Page:124-134
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:

Author:

Stahl Neil,Radin Allen,Mellis Scott

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Reference39 articles.

1. General mechanisms of cytokine receptor signaling;Carpenter;Adv. Protein Chem.,1998

2. Cytokine traps: multi-component, high-affinity blockers of cytokine action;Economides;Nat. Med.,2003

3. Setting the cytokine trap for autoimmunity;Dinarello;Nat. Med.,2003

4. The efficacy of inhibiting tumour necrosis factor alpha and interleukin 1 in patients with rheumatoid arthritis: a meta-analysis and adjusted indirect comparisons;Nixon;Rheumatology (Oxford),2007

5. Effects of IL-1 Trap on biochemical markers of inflammation and joint tissue breakdown in patients with rheumatoid arthritis;Garnero;Arthritis Rheum.,2005

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and Genetic Spectrum of Nine Cases of NLRP3-Associated Autoinflammatory Disease (NLRP3-AID) and Identification of One Novel NLRP3 Mutation by Genetic Variation Analyses;Journal of Immunology Research;2024-03-06

2. Mechanism of inflammasomes in cancer and targeted therapies;Frontiers in Oncology;2023-03-20

3. Therapeutic Potential of Targeting the NLRP3 Inflammasome in Rheumatoid Arthritis;Inflammation;2023-03-10

4. Diagnostic value of different interleukins and procalcitonin in critically ill patients admitted with suspected sepsis;Indian Journal of Pathology and Microbiology;2022-01

5. Biologic Drugs for Rheumatoid Arthritis in the Context of Biosimilars, Genetics, Epigenetics and COVID-19 Treatment;Cells;2021-02-04